5GIANNI I,VIGANO I,LOCATELLI A,et al.Huinan pharmacokinetic chatacterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer[J].Clin Oneol,1997,15(2):1906.
6ELLIS A G,CRINIS N A,WEBSTER 1 K.Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor El and Tween 80[J].Cancer Chemother Pharmacol,1996,38(5):81.
7SPARREBOOM A,VAN ASPEREN J,MAYER U,et al.Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxo1) caused by P-glycoprotein in the intestine[J].Proc Natl Acad Sci of USA,1997,94(12):2031.
8Hyams JS. Sorbitol intolerance: an unappreciatied cause of functional gastrointestinal complaints[J]. Gastroenterology, 1983,84(1):30.
9Veerman MW. Excipients in valproic acid syrup may cause diarrhea:a case report[J]. DICP,1990,24(9):832.
10ten Tije A J, Verweij J, Nooter K, et al. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy[J]. Clin Pharmacokinet, 2003,42(7):665.
